The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure

[1]  K. Shin‐ya,et al.  Inhibition of histone H3K9 methyltransferases by gliotoxin and related epipolythiodioxopiperazines , 2014, The Journal of Antibiotics.

[2]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[3]  V. Roger.  Epidemiology of Heart Failure , 2013, Circulation research.

[4]  C. Grosan,et al.  Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3. , 2013, Human molecular genetics.

[5]  Robert Brown,et al.  Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases. , 2013, Nature chemical biology.

[6]  J. Backs,et al.  HDAC4 controls histone methylation in response to elevated cardiac load. , 2013, The Journal of clinical investigation.

[7]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[8]  D. Pfaff,et al.  Acute stress and hippocampal histone H3 lysine 9 trimethylation, a retrotransposon silencing response , 2012, Proceedings of the National Academy of Sciences.

[9]  G. Vance,et al.  Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability , 2012, Oncogene.

[10]  Alberto D. Pascual-Montano,et al.  GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics , 2012, Nucleic Acids Res..

[11]  H. Ventura,et al.  Developments in heart failure 2011. , 2012, Congestive heart failure.

[12]  T. McKinsey.  Therapeutic potential for HDAC inhibitors in the heart. , 2012, Annual review of pharmacology and toxicology.

[13]  David A. Knowles,et al.  Distinct Epigenomic Features in End-Stage Failing Human Hearts , 2011, Circulation.

[14]  J. Jalife,et al.  Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. , 2011, The Journal of clinical investigation.

[15]  De-Pei Liu,et al.  The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. , 2011, The Journal of clinical investigation.

[16]  Dian J. Cao,et al.  Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy , 2011, Proceedings of the National Academy of Sciences.

[17]  S. Shroff,et al.  HDAC3-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity* , 2010, The Journal of Biological Chemistry.

[18]  D. Edwards,et al.  HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes. , 2010, Matrix biology : journal of the International Society for Matrix Biology.

[19]  N. Mariappan,et al.  HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive Rats , 2010, Hypertension.

[20]  T. Guo,et al.  Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. , 2010, American journal of physiology. Heart and circulatory physiology.

[21]  Alexander M. Wolf,et al.  Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. , 2010, The Journal of nutritional biochemistry.

[22]  A. Fenning,et al.  Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive rats , 2010, British journal of pharmacology.

[23]  H. Kee,et al.  Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. , 2009, Journal of molecular and cellular cardiology.

[24]  Alexander M. Wolf,et al.  Metabolic Remodeling Induced by Mitochondrial Aldehyde Stress Stimulates Tolerance to Oxidative Stress in the Heart , 2009, Circulation research.

[25]  Danny Reinberg,et al.  Histones: annotating chromatin. , 2009, Annual review of genetics.

[26]  M. Asakura,et al.  Global gene expression profiling in the failing myocardium. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[27]  John Quackenbush,et al.  Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. , 2009, Genomics.

[28]  Francisco Tirado,et al.  GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information , 2009, Nucleic Acids Res..

[29]  D. Gardner,et al.  Endothelin-Stimulated Human B-Type Natriuretic Peptide Gene Expression Is Mediated by Yin Yang 1 in Association With Histone Deacetylase 2 , 2009, Hypertension.

[30]  K. Shimada,et al.  Genome‐wide histone methylation profile for heart failure , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[31]  K. Webster,et al.  Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300 , 2008, Circulation.

[32]  E. Olson,et al.  Deacetylase inhibition promotes the generation and function of regulatory T cells , 2007, Nature Medicine.

[33]  K. Bible,et al.  Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress. , 2007, Blood.

[34]  J. Carazo,et al.  GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists , 2007, Genome Biology.

[35]  Ulrich Mansmann,et al.  Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. , 2006, Journal of the American College of Cardiology.

[36]  E. Olson,et al.  Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy , 2006, Circulation.

[37]  Axel Imhof,et al.  Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9 , 2005, Nature chemical biology.

[38]  Raimond L Winslow,et al.  Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. , 2004, Genomics.

[39]  Y. Kaneda,et al.  Lamr1 functional retroposon causes right ventricular dysplasia in mice , 2004, Nature Genetics.

[40]  Hans Lehrach,et al.  Expression profiling of human idiopathic dilated cardiomyopathy. , 2003, Cardiovascular research.

[41]  S. Papa.  The NDUFS4 nuclear gene of complex I of mitochondria and the cAMP cascade. , 2002, Biochimica et biophysica acta.

[42]  Chun Li Zhang,et al.  Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.

[43]  Paul D Allen,et al.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. , 2002, The American journal of pathology.

[44]  Stephen Rea,et al.  Central role of Drosophila SU(VAR)3–9 in histone H3‐K9 methylation and heterochromatic gene silencing , 2002, The EMBO journal.

[45]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[46]  C. Clarke,et al.  Isolation and Functional Expression of Human COQ3, a Gene Encoding a Methyltransferase Required for Ubiquinone Biosynthesis* , 2000, The Journal of Biological Chemistry.

[47]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[48]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[49]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[50]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[51]  U. Francke,et al.  Molecular cloning of cDNAs encoding rat and human medium-chain acyl-CoA dehydrogenase and assignment of the gene to human chromosome 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Weber,et al.  [Isolation and configuration of Chaetocin]. , 1970, Helvetica chimica acta.